SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
MiraLax Safe for Chronic Constipation
July 25, 2007
 · 
1 min read
Drug Development
University of Minnesota Study Identifies Medication that Helps People with Obsessive-compulsive Disorder
July 24, 2007
 · 
1 min read
Drug Development
Abortion Pill Could Become Daily Contraceptive
July 18, 2007
 · 
1 min read
Drug Development
Quitting with Rimonabant -- 20 mg Dose Can Help, and Can Prevent Weight Gain
July 18, 2007
 · 
1 min read
Drug Development
New Drug Combo Helps HIV Patients with Few Options
July 6, 2007
 · 
1 min read
Drug Development
GlaxoSmithKline (Jobs)'s Avandia Stirs Debate at Diabetes Meeting
June 26, 2007
 · 
1 min read
Drug Development
Results Mixed on Postmarketing Studies of New Drugs, According to the Tufts Center for the Study of Drug Development
May 15, 2007
 · 
1 min read
Drug Development
Pfizer Inc. (Jobs) “Good Cholesterol” Drug Fails to Cut Plaque
March 26, 2007
 · 
4 min read
Drug Development
AstraZeneca PLC(Jobs)'s Crestor Not As Effective As Hoped
March 26, 2007
 · 
1 min read
Drug Development
Avastin Fails Trials For Pancreatic Cancer
January 24, 2007
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Teva Pharmaceutical Industries Limited Announces Positive Results from a Study Assessing a New Formulation of Copaxone(R)
June 4, 2010
 · 
1 min read
Drug Development
BioSyent Inc. Initiates Voluntary Drug Recall
June 3, 2010
 · 
2 min read
Drug Development
US FDA Orders New Warnings for GlaxoSmithKline, AstraZeneca PLC Drugs
June 3, 2010
 · 
1 min read
Drug Development
Prometheus Laboratories Inc. to Present New Data on Proprietary Oncology Diagnostic Platform at American Society of Clinical Oncology Annual Meeting
June 2, 2010
 · 
6 min read
Drug Development
Teva Neuroscience, Inc. Release: Recently Published Clinical Pharmacology Study Confirms Azilect(R) Selectively Inhibits MAO-B at Approved Doses
June 2, 2010
 · 
1 min read
Drug Development
Ferring Pharmaceuticals: FIRMAGON(R) Results in Fast, Long-Term Suppression of Testosterone in Prostate Cancer Patients Without Initial Testosterone Surge
June 2, 2010
 · 
6 min read
Drug Development
UK’s NICE Backs First-line Use of Johnson & Johnson’s Velcade
June 2, 2010
 · 
1 min read
Drug Development
EpiCept Corporation Announces Fulfillment of Ceplene’s Third European Post-Approval Commitment
June 1, 2010
 · 
1 min read
Drug Development
Dendreon Corporation Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting
June 1, 2010
 · 
4 min read
Drug Development
UK’s NICE Rejects Novartis AG’s Xolair for Children
June 1, 2010
 · 
3 min read
Drug Development
Advanced Life Sciences Holdings, Inc. Announces Restanza(TM) Shows Efficacy Against Malaria
May 26, 2010
 · 
5 min read
Drug Development
Shire plc: Study Evaluated Vyvanse(R) Capsules CII Efficacy and Safety in Adolescents with ADHD
May 26, 2010
 · 
9 min read
Drug Development
McNeil Pediatrics: New Data Analyses of CONCERTA(R) Efficacy on ADHD in the Classroom
May 26, 2010
 · 
8 min read
Drug Development
Teva Pharmaceutical Industries Limited Targets Roche Holding AG’s Rituxan in Biosimilar Drug Trial
May 25, 2010
 · 
1 min read
Drug Development
Ortho-McNeil-Janssen Pharmaceuticals, Inc.: New Data on INVEGA(R) SUSTENNA(R) and RISPERDAL(R) CONSTA(R) for Schizophrenia to be Presented at Major Psychiatry Meeting
May 24, 2010
 · 
10 min read
Drug Development
Bayer HealthCare Pharmaceuticals Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting
May 21, 2010
 · 
8 min read
Drug Development
Ortho-McNeil Janssen Scientific Affairs, LLC New Data on INVEGA(R) SUSTENNA(R) And RISPERDAL(R) CONSTA(R) for Schizophrenia to be Presented at Major Psychiatry Meeting
May 21, 2010
 · 
10 min read
Drug Development
Shire plc Study Data Show INTUNIV(TM) (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents
May 21, 2010
 · 
10 min read
Drug Development
Asthmatx, Inc.: Bronchial Thermoplasty Demonstrates Long Term Safety Benefits in Asthma Patients
May 20, 2010
 · 
4 min read
Drug Development
Ferring Pharmaceuticals Clinical Data Demonstrates That LYSTEDA(TM) Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB
May 19, 2010
 · 
6 min read
Load More